Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience

Hassan Raza, Braira Wahid, Ghazala Rubi, Adil Gulzar

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-2019 is a new global health challenge which causes severe respiratory complications. As of May 17th, 2020, SARS-CoV-2 has infected 4.6 million people and caused 310,000 deaths, worldwide. In order to study potential impact of infection, complete epidemiological information should be reported on regular basis however, data from Pakistan has not yet been published. This retrospective study is the first report of epidemiological trends of COVID-19 in Faisalabad, Pakistan. On April 4th, 2020, 128 nasopharyngeal swabs collected from city Faisalabad were transported to Postgraduate Research Institute, Lahore for further processing. RNA was extracted using QIAsymphony DSP Virus/Pathogen Midi Kit and real-time PCR was performed to quantify COVID-19. Our finding showed that overall prevalence of COVID-19 in Faisalabad on April 4th was 17.18% (22 of 128). Prevalence was higher in males (n = 17; 77.2%) as compared to females (n = 5; 22.8%) but this gender-wise difference was not statistically significant. Patients belonging to age group 37–47 years were found to be most (45.5%) infected with COVID-19.

Original languageEnglish
Article number104374
Number of pages3
JournalInfection, Genetics and Evolution
Volume84
DOIs
Publication statusPublished - Oct 2020
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CODID-19
  • Epidemiology
  • Pakistan
  • SARS-CoV-2

Fingerprint

Dive into the research topics of 'Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience'. Together they form a unique fingerprint.

Cite this